Press Release ZenaTech’s ZenaDrone Begins Testing Phase for Interceptor P-1 Counter-UAS Drone Platform ZenaTech Inc. · Jul 28
Press Release PMGC Holdings Inc. Announces Strategic Investment in Precision Aerospace & Defense Group and Long-Term Aerospace and Defense Manufacturing Agreement Through A&B Aerospace Inc. PMGC Holdings Inc. · Jul 28
Press Release Plus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference Plus Therapeutics Inc. · Jul 28
Press Release Palvella Therapeutics to Host Second Quarter 2026 Financial Results and Corporate Update Conference Call on August 4, 2026 Palvella Therapeutics Inc. · Jul 28
Press Release Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD) Dyne Therapeutics, Inc. · Jul 28
Press Release Trevi Therapeutics to Participate in Upcoming August Conferences Trevi Therapeutics, Inc. · Jul 28
Press Release Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution Kiniksa Pharmaceuticals International, Plc · Jul 28
Press Release Riot Announces Second Quarter 2026 Earnings Conference Call Riot Platforms, Inc. · Jul 28
Press Release China Literature to Report First Half 2026 Financial Results on August 11, 2026 China Literature · Jul 28
Press Release National Civil Rights Museum Hosts the 2026 Ruby Bridges Reading Festival National Civil Rights Museum · Jul 28
Press Release Department of Culture and Tourism – Abu Dhabi Announces 11 December 2026 Opening of Guggenheim Abu Dhabi Department of Culture and Tourism - Abu Dhabi · Jul 28
Press Release Antag Therapeutics Announces Dosing of First Patient in Phase 2a Trial of First-in-Class GIPR Antagonist AT7687 Antag Therapeutics · Jul 28